Cargando…
In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicines
BACKGROUND: Targeted drug-carrying phage nanomedicines are a new class of nanomedicines that combines biological and chemical components into a modular nanometric drug delivery system. The core of the system is a filamentous phage particle that is produced in the bacterial host Escherichia coli. Tar...
Autores principales: | Vaks, Lilach, Benhar, Itai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281789/ https://www.ncbi.nlm.nih.gov/pubmed/22185583 http://dx.doi.org/10.1186/1477-3155-9-58 |
Ejemplares similares
-
Killing cancer cells by targeted drug-carrying phage nanomedicines
por: Bar, Hagit, et al.
Publicado: (2008) -
Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide Bonds
por: Vaks, Lilach, et al.
Publicado: (2018) -
Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles
por: Ju, Zhigang, et al.
Publicado: (2017) -
Chemical modulation of M13 bacteriophage and its functional opportunities for nanomedicine
por: Chung, Woo-Jae, et al.
Publicado: (2014) -
Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205
por: D'Apice, Luciana, et al.
Publicado: (2015)